baber/WOPTO huggingface dataset:
Patent NZ-330610-A (NZ)
Title: Use of aminoguanidine derivatives to inhibit synthesis of urea from plasma arginine
Inventor: BIANCHI MARINA
IPC: C07C275/38
Filed: 1995-01-19
Abstract: The production of medicaments containing a compound of Formula (I) or Formula (II) useful in inhibiting the synthesis of urea from plasma arginine, ameliorating cachexia or the deleterious effects of nitric oxide synthesis, of cytokine secretion or of tumour necrosis factor or for the treatment of endotoxic shock or neoplastic disease. Wherein Formula (I) is defined as: X2 is Ghy-CH-, Ghy-CCH3 or H; X1, X'1 and X'2 are independently Ghy-CH- or Ghy-CCH3; Ghy means an amidinohydrazone radical such as NH2C(=NH)-NH-N=; Z is -NH(CO)NH-, -(C6H4)-, -(C5NH3)- or -A-(CH2)n-A- with n being 2-10 and which is an optionally mono or di-C-methyl substituted or a mono or di-unsaturated derivative thereof and A is -NH(CO)-, -NH(CO)NH-, -NH- or -O- and salts thereof. Wherein Formula (II) is defined as: X1, X2 and X3 are independently Ghy-CH- or Ghy-CCH3; X'1, X'2 and X'3 are independently H, Ghy-CH- or Ghy-CCH3; Ghy is as defined above. Z is (C6H3) when m1, m2 and m3 is zero or Z is nitrogen when m1-m3 are independently 2-6 and A is -NH(CO)-, -NH(CO)NH-, -NH- or -O- and salts thereof.
Patent NZ-332430-A (NZ)
Title: Use of triazine-based UVAs as quenchers in paper-making processes
Inventor: ROHRINGER PETER
IPC: C07D251/42
Filed: 1997-05-22
Abstract: The disclosure provides a process for the inhibition (quenching) of the effect of anionic fluorescent whitening agents on a substrate, comprising treating the substrate with a triazine UVA compound pictured above.
Patent NZ-334512-A (NZ)
Title: Method of using tetracycline compounds for inhibition of nitric oxide production
Inventor: AMIN ASHOK R
IPC: A61P19/02
Filed: 1997-08-21
Abstract: The application is for a method of inhibiting the production of nitric oxide (NO) in an in vivo, in vitro, or ex vivo biological system. The method employs a tetracycline compound to inhibit the production of NO and/or to inhibit the expression or activity of an inducible isoform ot nitric oxide synthase (iNOS). Preferably, the tetraclycine compound has inhibitory activity for metalloproteinases. Also it is preferred that the tetracycline compound is provided to the biological system in an amount which has little or no antibacterial activity in the system. The method can be used to treat medical conditions in mammals characterized by NO production mediated by iNOS, including, for example, inflammatory conditions.
Patent NZ-500426-A (NZ)
Title: Portable strapping apparatus with rocker and tensioning wheel for strapping goods with a band
Inventor: DE FELICE LUDOVIGO
IPC: B65B13/32
Filed: 1999-10-19
Abstract: Provided is a strapping apparatus for strapping goods with a band, the strapping apparatus having a tensioning device which is operatively connected to a tensioning drive (2) and is intended for tensioning the band, a closure device (3) for sealing two ends of a band, a cutting off device (4), and a plurality of rewinding locks (5, 6) for fixing the band on the strapping apparatus, wherein the tensioning device is provided with a rocker arranged opposite a tensioning wheel, the rocker is mounted pivotably about a rocker axis, the tensioning wheel and the rocker can be moved towards each other and as a result the band can be clamped between the rocker and the tensioning wheel, and the band rests on the tensioning wheel with an angle of wrap.
Patent NZ-501851-A (NZ)
Title: Gray scale prediction and data compression methods
Inventor: PETERS MICHAEL ALAN
IPC: G06T9/00
Filed: 1998-06-04
Abstract: A method and apparatus for compression of data. The system provides for the application of a plurality of compression schemes to the data such that improved compression ratios are achieved. A first embodiment provides for compression of each pixel by one of a plurality of different entropy-based compression schemes based upon a probability cost analysis. A second embodiment provides for compression of each pixel based on a hybrid context formed using a plurality of compression schemes for improved probability determination, and thus improved entropy encoding. In embodiments of the invention, a context compression scheme similar to JBIG is applied, as well as an inverse scheme. The context scheme forms a statistical context from a concatenated sequence of previous pixel values. The inverse scheme provides a gray value estimation method based upon previous pixel values and respective threshold values. Statistics are maintained with respect to the actual current pixel value and the difference between an estimated gray value and the current pixel threshold value.
Patent NZ-502898-A (NZ)
Title: Rotary grinding mill for size reduction of particles
Inventor: KELSEY CHRISTOPHER GEORGE
IPC: B02C19/11
Filed: 1998-08-28
Abstract: A grinding mill has a rotating container (40) into which particulate material is fed. The container is rotated above critical speed to form a layer which is retained under high pressure against the container inner surface. Shearing discs (58) mounted inside the container induce shearing of the layer to promote particle fracture by shearing and abrasion in the pressurised layer. Fine ground material travels axially to the container discharge end. In one form, the container is rotated at sufficient speed to form a series of solidified zones (70) alternated with stirred zones (72) next to non-rotating shearing discs (58). These solidified zones act as solid discs rotating with the container.
Patent NZ-503946-A (NZ)
Title: Oral dosage form in an oval or caplet shape for administration of bisphosphonates and other known medicaments
Inventor: DANSEREAU RICHARD JOHN
IPC: A61K9/36
Filed: 1998-06-08
Abstract: Described is an oral dosage form to be delivered to the stomach comprising an active ingredient selected from the group consisting of tetracycline antibiotics, iron preparations, quinidine, nonsteroidal anti-inflammatory drugs, alprenolol, ascorbic acid, captopril, theophylline, zidovoudine, bisphosphonates or mixtures thereof and pharmaceutically-acceptable excipients.  The oral dosage form is generally oval in shape and film-coated to facilitate rapid oesophageal transit and avoid irritation to the mouth, buccal cavity, pharynx and oesophagus.
Patent NZ-504512-A (NZ)
Title: Peptide from alpha-hemoglobin as a stimulator of stem cell proliferation and used thereof
Inventor: WOLPE STEPHEN D
IPC: C07K14/805
Filed: 2000-05-12
Abstract: Polypeptides are provided that include a haemoglobin alpha chain wherein the C-terminal hydrophobic domain has been biotinylated or iodised, and compositions containing them.  The peptides may be used in medicaments or pharmaceutical compositions to regulate the stem cell cycle to treat cancer, myeloproliferative diseases, myelodysplasia, aplastic anaemia, immune deficiency, ageing, other hyper- or hypo-proliferative diseases and pain.
Patent NZ-507707-A (NZ)
Title: Gellable pharmaceutical compositions comprising active substance, phospholipid, solvent and fatty acid and their use for the controlled release of one or more active substances by subcutaneous and/or intramuscular injection
Inventor: FANARA DOMENICO
IPC: A61K45/00
Filed: 1999-04-16
Abstract: A fluid pharmaceutical composition which allows the release of at least one active substance and which comprises: i) A therapeutically effective amount of at least one active substance; ii) From 3 to 55% by weight of phospholipid; iii) From 16 to 72% by weight of pharmaceutically acceptable solvent; and iv) From 4 to 52% by weight of fatty acid; The composition has the property of gelling instantaneously in the presence of an aqueous phase. The above described pharmaceutical composition is useful for the controlled release of one or more substances by subcutaneous and/or intramuscular injection wherein the medicament has the property of gelling instantaneously in the presence of an aqueous phase.
Patent NZ-508379-A (NZ)
Title: Waste water disposal apparatus located on a sloping surface having a permeable layer covering baffles
Inventor: SCANLEN DEAN RODNEY
IPC: A61K47/20
Filed: 2000-11-24
Abstract: A waste water disposal apparatus for a sloping surface comprising, at least one layer of permeable material (7), at least one impermeable (9,10) cover adapted to at least partially cover one or more of the permeable layers (7) and at least one baffle (5) positioned along a contour line of the slope.  The permeable layer (7) is located on the sloping surface above the baffle (5).
Patent NZ-511070-A (NZ)
Title: High performance lithium ion polymer cells and batteries
Inventor: XUE JIAY SIMON
IPC: H01M4/36
Filed: 1998-10-13
Abstract: A   non-aqueous  rechargeable  electrochemical   cell comprising  an  anode, a cathode and a  polymeric  separator therebetween, with a non-aqueous electrolyte, comprising  an electrolyte salt dissolved in a solvent therefore, being  in contact  with the anode, cathode and separator.   The  anode and  cathode comprise different intercalation compounds  for host  containment and release of lithium ions, characterized in  that  a  non-cathode active lithium compound  containing one  or  more non-metallic elements, substantially insoluble in  the  non-aqueous electrolyte of the cell,  is  dispersed throughout the cathode.
Patent NZ-512465-A (NZ)
Title: Method and apparatus for manufacturing an optical fibre cable and cable so manufactured
Inventor: MARELLI PAOLO
IPC: H01B13/00
Filed: 1999-12-06
Abstract: Undesired and unforeseeable shrinkage may occur in a tube of plastic material containing optical fibres following its manufacture, especially during storage when the tube is wound on a reel.  As a result, there may be uncontrollable variations of the ratio between length of the tube and length of the optical fibre contained therein ("excess fibre variation").  The present disclosure relates to a method and equipment for limiting the excess fibre variations in a plastic tube, by stretching the tube by a predefined amount during manufacturing.  The present disclosure also relates to a plastic tube subjected to a predefined stretching, a cable comprising such a tube and the equipment suitable for manufacturing such tube.
Patent NZ-514077-A (NZ)
Title: Treatment of Α-galactosidase A deficiency
Inventor: SELDEN RICHARD F
IPC: A61K48/00
Filed: 2000-03-09
Abstract: Use of a human á-galactosidase A (á-Gal A) preparation in the manufacture of a medicament for the treatment of á- Gal A deficiency, for example the treatment of Fabrys disease, wherein the medicament is formulated to provide a unit dose between about 0.1 and about 0.3 mg of á-Gal A per kilogram of body weight, and wherein more than 50% of the total glycans of said preparation are complex-type glycans.
Patent NZ-516082-A (NZ)
Title: Compact power generation apparatus and method of generating energy
Inventor: NORDENTOFT TORSTEN
IPC: F02B63/04
Filed: 2000-05-17
Abstract: The present invention relates to a compact power generation apparatus for the generation of energy for powering various appliances, such as domestic appliances, comprising a housing accommodating an air cooled internal combustion engine, generator driven by the engine for the generation of electrical power, an exhaust system, an inlet communicating with an outlet and flow generating means for circulating a cooling air flow through and around the generator, the engine and the exhaust, wherein heat exchanging means are provided for extracting heat from the exhaust system and from the circulating air flow and passing said extracted heat on to a utility medium, such as air or water for utility purposes. Moreover, the invention relates to a method of generating energy, a method of automated power management of a compact power generation apparatus, and a power management system for carrying out this method.
Patent NZ-516737-A (NZ)
Title: Rapid growing microorganisms for biotechnology applications
Inventor: BLOOM FREDRIC R
IPC: C12N1/15
Filed: 2000-06-19
Abstract: Isolated E.coli lacking endogenous plasmids having a growth rate that is at least 5% greater than the growth rate of a reference organism selected from the group consisting of E. coli MM294, DHá and DH10B. Also described is a method of cloning, producing a protein or polypeptide and transforming E.coli.
Patent NZ-517191-A (NZ)
Title: Method of surface modifying a medical tubing
Inventor: QIN CHUAN
IPC: B29C48/91
Filed: 2000-08-31
Abstract: A  method for fabricating a medical tubing  comprising the steps of : a)  providing a material selected from the group  consisting of   ethylene  homopolymers  and  ethylene  copolymers.  The ethylene  copolymers are obtained by copolymerizing ethylene with a comonomer selected from the group consisting of lower alkyl  olefins, lower alkyl esters of a carboxylic acid  and lower alkene esters of a carboxylic acid or blends thereof. b) providing an extruder with an extrusion die; c) extruding the material into a medical tubing; d) providing a surface modifier solution; e) preheating the surface modifier solution to a temperature within the range of 30-95 C; f)  applying  the preheated solution onto the tubing  at  it exits the extrusion die when the tubing is in a molten state or a semi-molten state.
Patent NZ-519760-A (NZ)
Title: Information transmission with different catagories representing the urgency of reception processing
Inventor: ASAMI KAZUO
IPC: H04B7/26
Filed: 2001-03-15
Abstract: An information transmission method includes a dedicated information transmission channel assigned exclusively to transmission of information sent out for broadcasting business, transmitting several different sets of information in a time sharing mode in unoccupied time slots within the information transmission channel, the unoccupied time slots obtained by compressing the information for broadcasting business. An information transmission system can be used to perform the information transmission method.
Patent NZ-526360-A (NZ)
Title: A Panel Edge Modification Device or Unit for a Contour Edge Banding Device
Inventor: SUCH DUNCAN KARL
IPC: B29C63/00
Filed: 2003-05-30
Abstract: An edge banding apparatus for the application of an edge tape to at least part of an edge of a substantially planar panel said edge defining a perimeter of said panel of an arbitrary profile, said apparatus comprising a means to mount said panel on a fixed structure and an edge follower including at least one edge contact roller to follow at least part of the perimeter of said panel. An edge follower support structure to allows displacement of said edge follower relative to the fixed structure and when in use, relative to a said panel. An edge sensor is capable of determining the slope, of said profile of said panel at where said edge follower is engaged to said panel, relative to a fixed frame of reference. Force application means applies a vectored force to said edge follower to bias said at least one contact roller toward the edge of said panel, said force application means is capable of vectoring the force applied to said edge follower relative to said fixed frame of reference and in response to the shape determined from said edge sensor, in a manner to vector the resultant force to said edge follower in a direction to bias said at least one contact roller towards said edge and not along said edge (save for optionally a very small component in or against the direction of travel of said edge follower along said profile). Means are included to generate relative movement between said edge follower and said planar object to thereby induce movement of said edge follower along at least part of the profile wherein said edge follower includes a tape feeding means which allows for the feeding of tape onto the edge of said panel
Patent NZ-527711-A (NZ)
Title: Method for franking postal deliveries and a graphical user interface for carrying out said method
Inventor: LANG JURGEN
IPC: G06Q50/00
Filed: 2002-03-19
Abstract: A method of operating a machine with a user interface for franking postal deliveries is disclosed. The franking is controlled by a graphical user interface with includes a graphical representation of a design of a postage indicium to be generated. The screen menu contains a command panel for selecting franking options, and this screen menu opens when the graphical representation of a design of the postage indicium, embedded in a screen display of a text document, is selected.
Patent NZ-530040-A (NZ)
Title: Solid pharmaceutical formulations comprising modafinil
Inventor: CORVARI VINCENT
IPC: A61P1/14
Filed: 2002-05-24
Abstract: Disclosed is a composition comprising modafinil; one or more diluents, each independently chosen from a starch, a lactose monohydrate or a microcrystalline cellulose; one or more disintegrants, each independently chosen from a pregelatinized starch or a cross-linked sodium carboxymethyl cellulose; a binder; and a lubricant; wherein modafinil comprises from about 30-50% by weight of the composition; a diluent is a lactose monohydrate, a second diluent is a microcrystalline cellulose; a disintegrant is a pregelatinized starch, a second disintegrant is a cross-linked sodium carboxymethyl cellulose; the binder is a polyvinyl pyrrolidone, and the lubricant is magnesium stearate; provided the composition does not include magnesium silicate or talc. Further disclosed is the use of the composition in the manufacture of a medicament for the treatment of sleepiness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, ADHD, fatigue, cognitive dysfunction and for the promotion of wakefulness.
Patent NZ-530542-A (NZ)
Title: Flexible tubing having an inner laminated wall of thermoplastic silicone rubber and an outer laminated wall of olefin polymeric rubber
Inventor: THOMSON THOMAS DAWSON
IPC: F16L11/04
Filed: 2004-01-12
Abstract: Flexible tubing for aqueous systems derived from laminated polymeric materials. The tubing has inner and outer walls wherein the inner laminated wall of the tubing is resistant bacteria and consists of thermoplastic silicone rubber and the outer laminated wall of the tubing consists of polymeric rubber derived from a polymeric blend comprising olefin polymers.
Patent NZ-534012-A (NZ)
Title: Substituted phenylacetic acid ester compounds as short-acting sedative hypnotic agents for anesthesia and sedation
Inventor: JENKINS THOMAS E
IPC: C07D229/02
Filed: 2003-01-24
Abstract: Substituted phenylacetic acid ester compounds of formula (I) that are useful as short-acting sedative hypnotic agents for anesthesia and sedation are disclosed: wherein R1 is selected from the group consisting of (C2-C6) alkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, (C3-C6) cycloalkyl (C1-C6) alkyl, phenyl, and benzyl; R2 and R3 are each independently selected from the group consisting of (C1-C6) alkyl, (C2-C6) alkenyl, and (C2-C6) alkynyl, or R2 and R3, together with the nitrogen atom to which they are attached, form a heterocyclic ring having from 5 to 7 atoms; and R4 is selected from the group consisting of (C1-C6) alkyl, (C2-C6) alkenyl, and (C2-C6) alkynyl; provided that the sum of the number of carbon atoms in R1, R2, R3, and R4 is greater than 7.
Patent NZ-534325-A (NZ)
Title: Cable guardrail release system
Inventor: BLIGH ROGER P
IPC: E01F15/06
Filed: 2003-01-30
Abstract: A cable guardrail release system (10) includes a first number of anchor posts (12, 14, 16) installed adjacent a roadway. Each of the first number of anchor posts (12, 14, 16) secures an end of a respective cable (12, 24, 26). Each anchor post (12, 14, 16) is operable to release the respective cable (12, 24, 26) secured by the anchor post (12, 14, 16) upon a vehicle impact to the anchor post (12, 14, 16). The system (10) may include a length of need section that includes a plurality of intermediate support posts (18, 20) each configured to support each of the respective cables (22, 24, 26). The length of need section may include portions of each of the respective cables (22, 24, 26) running in between the plurality of intermediate support posts (18, 20). Each anchor post (12, 14, 16) may be configured to resist release of the respective cable (22, 24, 26) secured by the anchor post (2, 14, 16) upon a vehicle impact to the length of need section generally at an angle to the flow of traffic on the roadway.
Patent NZ-536206-A (NZ)
Title: Vial including an implant holding member for retaining an implant containing a beneficial agent
Inventor: DAVIS CRAIG R
IPC: A61J1/00
Filed: 1998-12-15
Abstract: A vial 90 for holding an implant 18 containing a beneficial agent to be delivered subcutaneously to a patient is disclosed. The vial includes an open body with an implant holding member 96 for retaining the implant. A tapered mouth is provided for directing a cannula 14 into the open end of the vial and around the implant. A stopper 92 with a sealing surface is included to close the vial and seal a dispensing opening of the implant to prevent the beneficial agent leaking.
Patent NZ-542840-A (NZ)
Title: Joint fill composition and method for protecting pipeline joints
Inventor: BROWN SCOTT A
IPC: C08G18/00
Filed: 2004-03-08
Abstract: A method for filling a gap at the junction between two lengths of coated pipe, the method comprising: enclosing the gap with a mold having an opening; introducing a joint filling composition into the mold; and allowing the joint fill composition to react and form a polymeric foam; wherein the joint filling composition comprises: an A-side component comprising between about 75 weight % to about 85 weight % of polymeric MDI and between about 15 weight % and about 25 weight % 2,2,4-trimethyl-1,2-pentanediol diisobutyrate; and as B-side component comprising between about 35 weight % and about 45 weight % of amine based polyether polyol, and about 50 weight % to about 65 weight % 2,2,4-trimethyl-1,2-pentanediol diisobutyrate.
Patent NZ-543915-A (NZ)
Title: Anthranilic acid amides for use in retinopathy or neoplastic disease, and their process of preparation
Inventor: BOLD GUIDO
Filed: 2002-11-07
Abstract: Disclosed are anthranilic acid amide derivatives of formula (I), N-oxides, tautomers, and salts of such amides, as well as the processes for their preparation. Ar is explained to be represented by the sub-formula (Ia); Ra represents H or lower alkyl; R1 represents H or perfluoro lower alkyl; and R2 represents H, halogen, C2-C7alkyl, C2-C7alkenyl or lower alkynyl. Use of the amides is described to be for the treatment of a neoplastic disease, such as a tumor disease, or retinopathy or age-related macular degeneration.
Patent NZ-543940-A (NZ)
Title: Determining the ratio of genomic DNA and mtDNA or their related gene products with regards to determining the stage of an asymptomatic disease
Inventor: VAN GEMEN BOB
IPC: C12Q1/68
Filed: 2001-12-04
Abstract: Disclosed is a method for determining the staging of a disease, comprising determining the relative ratio of an endosymbiont cellular organelle nucleic acid and/or gene product thereof in relation to the amount of a nuclear nucleic acid and/or gene product thereof in a sample obtained from an organism suffering from or at risk of suffering from said disease. (62) Divided Out of 526519